Search for: "Freedom Pharmaceuticals, Inc"
Results 101 - 120
of 152
Sorted by Relevance
|
Sort by Date
22 Nov 2011, 11:02 am
IMS Health Inc., 131 S. [read post]
7 Feb 2023, 6:19 pm
The program is funded jointly by states and the federal government.Mallinckrodt ARD LLC, previously Questcor Pharmaceuticals Inc., paid $260 million to resolve separate allegations relating to its drug H.P. [read post]
23 Jan 2017, 1:25 am
Attendance is free, but RSVP essential, to emma@hartpub.co.uk or via this link. 24 March 2017, the European Centre for Press and Media Freedom conference on Media Freedom in Strasbourg, entitled: “Promoting dialogue between the ECtHR and the media freedom community” Media Law in Other Jurisdictions Canada On 17 January 2017, Funt J gave judgment in the case of Kazakoff v. [read post]
30 May 2019, 5:09 am
” Informed, Inc. [read post]
22 Nov 2010, 11:02 am
American Promotional Events, Inc. [read post]
7 Dec 2011, 6:21 pm
Prometheus Laboratories, Inc. [read post]
6 Oct 2014, 5:36 am
Another clash looms over the issue of religious freedom. [read post]
2 May 2012, 4:47 am
Manufactured by Bayer Healthcare Pharmaceuticals, Inc., Mirena is an IUD device [intrauterine device] that must be inserted by a trained health care provider and is intended to provide contraceptive protection for up to five years. [read post]
25 Mar 2011, 1:01 pm
Nebraska announced in January that it had acquired 500 grams from Kayem Pharmaceutics of India, the minimum amount available for sale. [read post]
24 Mar 2012, 6:17 am
Manufactured by Bayer Healthcare Pharmaceuticals, Inc., Mirena is an IUD device [intrauterine device] that must be inserted by a trained health care provider and is intended to provide contraceptive protection for up to five years. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
28 Jun 2013, 6:01 pm
Praxair Canada Inc., [1998] O.J. [read post]
9 May 2008, 10:30 pm
, US: ACI ‘In-house counsel forum on pharmaceutical antitrust’ – 20-21 May, Maryland: (Orange Book Blog), EU: Workshop for mediators in IP disputes – 26-27 May, Geneva: (IPR-Helpdesk), US: PLI: ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – 28 May, New York / 11 June, San Francisco: (Patent Docs), US: Worldwide Business Research: PharmaBiotech IP summit –… [read post]
20 Jun 2018, 4:12 am
Note that Meyerlustenberger Lachenal AG has been involved in this matter on behalf of Gilead) The Swiss dispute in a nutshell The Swiss litigation is about the validity of Gilead Sciences Inc. [read post]
8 Mar 2018, 11:35 am
Sanderson Farms, Inc., No. 3:17-cv-03592-RS (N.D. [read post]
18 Nov 2014, 1:28 pm
Trucking Ass’ns, Inc. v. [read post]
8 Dec 2007, 6:30 pm
Ag Supply, Inc., 200 F.3d 1374 (Fed. [read post]
28 Jan 2020, 9:58 pm
Utilizing the flexibility resulting from the Coix Order could help reduce health plan costs of compliance with the HIPAA right of access rule by allowing the health plan and its records providers more freedom to determine the charges and format for delivering PHI in response to records requests received from other insurers, lawyers and other third parties. [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
22 May 2014, 5:00 am
Pfizer, Inc., 2000 WL 1099884, at *2 & n.1 (S.D.N.Y. [read post]
